SEC Form D private-offering filing

ViCardia Therapeutics, Inc.

Name: ViCardia Therapeutics, Inc. - new SEC Form D private-offering filing, San Francisco, CA
Published: 2026-05-21

A new SEC Form D private-offering notice from San Francisco, CA, a $700,000 filer-stated offering target in Biotech. The source filing is one click away.

ViCardia Therapeutics, Inc. site↗ Verified via SEC Form D

ViCardia Therapeutics is a San Francisco clinical stage biopharmaceutical company developing GP531, an infusion therapy targeting mitochondrial dysfunction in heart failure.

Filed 2026-05-21Filed to raise $700,000First money in 2026-05-19Raised so far $700,000HQ (as filed) San Francisco, CASector Biotech ✓Stage (inferred) Pre-seedCall status Call-ready

Source linked the Form D on EDGAR↗Website verified vicardia.com↗Named in the filing 1 executive & director

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.